ライフサイエンスコーパス: hemodynamic monitoring

1 in 50 critically ill patients with advanced hemodynamic monitoring.

2 ction, including arterial catheters used for hemodynamic monitoring.

3 s to PCWP in ICU patients requiring invasive hemodynamic monitoring.

4 ed 40 patients in the ICU requiring invasive hemodynamic monitoring.

5 cular preload in patients requiring invasive hemodynamic monitoring.

6 ansesophageal echocardiography, and invasive hemodynamic monitoring.

7 equipment, and capability for full invasive hemodynamic monitoring.

8 went upright treadmill exercise testing with hemodynamic monitoring.

9 tobarbital (iv) and controlled by continuous hemodynamic monitoring.

10 e intensive care unit who underwent invasive hemodynamic monitoring.

11 All animals underwent invasive hemodynamic monitoring.

12 the comparative trial, which did not require hemodynamic monitoring, 305 patients were randomly assig

13 dmission included respiratory failure (57%), hemodynamic monitoring (32%), and shock (16%).

14 ith these factors may require more intensive hemodynamic monitoring after CAS, including prolongation

15 Noninvasive hemodynamic monitoring and an information system provide

16 exercise testing with simultaneous invasive hemodynamic monitoring and Doppler echocardiography.

17 Invasive hemodynamic monitoring and echocardiographic data were c

18 Hemodynamic monitoring and first-pass radionuclide ventr

19 rdiopulmonary exercise testing with invasive hemodynamic monitoring and first-pass radionuclide ventr

20 Hemodynamic monitoring and goal-directed fluid therapy u

21 e implantation, a maximal exercise test with hemodynamic monitoring and respiratory gas analysis was

22 g aggressive fluid resuscitation and careful hemodynamic monitoring and respiratory support.

23 patients cannot be explained by noninvasive hemodynamic monitoring and the patient fails to respond

24 s were prescribed have a higher frequency of hemodynamic monitoring and use of sedative and neuromusc

25 ventilated pigs were prepared surgically for hemodynamic monitoring and were subjected to a right tho

26 n addition to exchange transfusion, invasive hemodynamic monitoring, and aggressive ventilatory suppo

27 nce cardiography should not replace invasive hemodynamic monitoring at this time.

28 rate variability measured with non-invasive hemodynamic monitoring consisting of bioimpedance cardia

29 Data on the clinical use of left atrial (LA) hemodynamic monitoring during MitraClip procedure are li

30 In addition to standard invasive hemodynamic monitoring, electromagnetic flow probes were

31 tions (mechanical ventilation, intravascular hemodynamic monitoring, feeding tube placement, tracheos

32 ts with severe heart failure felt to require hemodynamic monitoring for the optimization of medical t

33 Hemodynamic monitoring has moved in the last few years f

34 pulmonary artery catheter during continuous hemodynamic monitoring in an intensive care unit setting

35 Using functional hemodynamic monitoring in brain-dead organ donors, we te

36 As in clinical trials, use of ambulatory hemodynamic monitoring in clinical practice is associate

37 This review discusses the role of hemodynamic monitoring in patients with acute heart fail

38 udy examined the effectiveness of ambulatory hemodynamic monitoring in reducing HFH outside of the cl

39 olemia or cardiogenic shock), while invasive hemodynamic monitoring is recommended only for select pa

40 and recommendations may range from invasive hemodynamic monitoring, management of proper inotropic s

41 to conservative medical management, invasive hemodynamic monitoring may be helpful in guiding managem

42 Hemodynamic monitoring might improve the day-to-day mana

43 tted to the intensive care unit for invasive hemodynamic monitoring of heart failure and if they had

44 ce (MR) imaging for noninvasive longitudinal hemodynamic monitoring of hepatic blood flow before and

45 ing is feasible for noninvasive longitudinal hemodynamic monitoring of hepatic blood flow before and

46 Hemodynamic monitoring of patients with a pulmonary arte

47 rdiopulmonary exercise testing with invasive hemodynamic monitoring on 104 patients with symptomatic

48 sing simple bedside calculations (functional hemodynamic monitoring); prior physiologic data of simil

49 Back in 2003, we started a hemodynamic monitoring protocol in adult living-donor li

50 riate resuscitation fluids, vasopressors and hemodynamic monitoring systems to maximize maternal and

51 locking agents used, mechanical ventilation, hemodynamic monitoring, Therapeutic Intervention Scoring

52 The addition of hemodynamic monitoring to clinical assessment does not p

53 Hemodynamic monitoring using transesophageal echocardiog

54 travenous treatment for acute HF and central hemodynamic monitoring were randomized to 24-h intraveno

55 Invasive hemodynamic monitoring with pulmonary artery catherizati